Search research articles
Contact Us
Filters
Showing results (121-130 of 491) with videos related to
Page
of 50
Sort By:
Pharmacotherapy
|
December 9, 2004
Atazanavir for the treatment of human immunodeficiency virus infection
Anthony J Busti, Ronald G Hall, David M Margolis
Viruses
|
August 26, 2023
New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
Catherine A Lewis, David M Margolis, Edward P Browne
High Altitude Medicine & Biology
|
April 3, 2020
Re: "High Carbohydrate Ingestion in High Altitude" by Pesta et al
Lee M Margolis, Andrew J Young, Stefan M Pasiakos
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 1, 2015
Optimized dietary strategies to protect skeletal muscle mass during periods of unavoidable energy deficit
Stefan M Pasiakos, Lee M Margolis, Jeb S Orr
The Journal of Infectious Diseases
|
April 19, 2008
Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells
Shailesh K Choudhary, Nancy M Archin, David M Margolis
Current Opinion in Clinical Nutrition and Metabolic Care
|
July 20, 2021
Challenging traditional carbohydrate intake recommendations for optimizing performance at high altitude
Stefan M Pasiakos, J Philip Karl, Lee M Margolis
Journal of the Endocrine Society
|
September 1, 2020
Effects of Testosterone on Serum Concentrations, Fat-free Mass, and Physical Performance by Population: A Meta-analysis
Alyssa N Varanoske, Lee M Margolis, Stefan M Pasiakos
Advances in Nutrition (Bethesda, Md.)
|
September 1, 2020
High-Fat Ketogenic Diets and Physical Performance: A Systematic Review
Nancy E Murphy, Christopher T Carrigan, Lee M Margolis
Plos Pathogens
|
September 3, 2025
HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells
Catherine A Lewis, David M Margolis, Edward P Browne
Drug Metabolism and Pharmacokinetics
|
October 30, 2007
In vitro metabolism of CP-122,721 ((2S,3S)-2-phenyl-3-[(5-trifluoromethoxy-2-methoxy)benzylamino]piperidine), a non-peptide antagonist of the substance P receptor
R Scott Obach, Jeannine M Margolis, Michael J Logman
Page
of 50
Search research articles
Search
Showing results (121-130 of 491) with videos related to
Sort By:
Page
of 50
Pharmacotherapy
|
December 9, 2004
Atazanavir for the treatment of human immunodeficiency virus infection
Anthony J Busti, Ronald G Hall, David M Margolis
Viruses
|
August 26, 2023
New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
Catherine A Lewis, David M Margolis, Edward P Browne
High Altitude Medicine & Biology
|
April 3, 2020
Re: "High Carbohydrate Ingestion in High Altitude" by Pesta et al
Lee M Margolis, Andrew J Young, Stefan M Pasiakos
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 1, 2015
Optimized dietary strategies to protect skeletal muscle mass during periods of unavoidable energy deficit
Stefan M Pasiakos, Lee M Margolis, Jeb S Orr
The Journal of Infectious Diseases
|
April 19, 2008
Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells
Shailesh K Choudhary, Nancy M Archin, David M Margolis
Current Opinion in Clinical Nutrition and Metabolic Care
|
July 20, 2021
Challenging traditional carbohydrate intake recommendations for optimizing performance at high altitude
Stefan M Pasiakos, J Philip Karl, Lee M Margolis
Journal of the Endocrine Society
|
September 1, 2020
Effects of Testosterone on Serum Concentrations, Fat-free Mass, and Physical Performance by Population: A Meta-analysis
Alyssa N Varanoske, Lee M Margolis, Stefan M Pasiakos
Advances in Nutrition (Bethesda, Md.)
|
September 1, 2020
High-Fat Ketogenic Diets and Physical Performance: A Systematic Review
Nancy E Murphy, Christopher T Carrigan, Lee M Margolis
Plos Pathogens
|
September 3, 2025
HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells
Catherine A Lewis, David M Margolis, Edward P Browne
Drug Metabolism and Pharmacokinetics
|
October 30, 2007
In vitro metabolism of CP-122,721 ((2S,3S)-2-phenyl-3-[(5-trifluoromethoxy-2-methoxy)benzylamino]piperidine), a non-peptide antagonist of the substance P receptor
R Scott Obach, Jeannine M Margolis, Michael J Logman
Page
of 50